-ELOSTERA Trademark

Pharmaceutical preparations for preventing spread of cancer cells; pharmaceutical preparations for mitigating negative side effects of chemo- and radiotherapy related to cancer; pharmaceutical preparations for controlling diabetes; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for use in chemotherapy; pharmaceutical preparations for treating malignant tumors; veterinary preparations, namely, preparations for preventing spread of cancer cells and mitigating negative side effects of chemo- and radiotherapy related to cancer; medical preparations for the reduction of side effects of chemotherapy and radiation therapy; pharmaceutical preparations for treating diabetes; pharmaceutical preparations and substances for use in oncology; pharmaceutical preparations and substances for the treatment of cancer; pharmaceutical drugs for the treatment of cancer; pharmaceutical preparations for human use for the treatment of cancer; pharmaceutical preparations and substances for the prevention of cancer; pharmaceutical compositions for the treatment and prevention of cancer; empty capsules for pharmaceuticals; nutritional supplements for veterinary use; dietary supplements for human beings and animals

Chemicals for use in industry and science; chemicals for use in biotechnological manufacturing processes; antioxidants for use in the manufacture of pharmaceuticals

Raw and unprocessed agricultural, aquacultural, horticultural and forestry products, namely, plant seeds, sowing seeds, crop seeds, unprocessed oil seeds, seeds for fruit and vegetables, seeds for planting, seeds for agricultural purposes, bitter melon seeds, genetically modified forms of all the aforementioned seeds